MedPath

Comparison of two doses of Dexmedetomidine for preventing delirium in wome

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/05/053201
Lead Sponsor
niversity College of Medical Siences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Adult female patients ( >18 years of age)

2. ASA I to III

3. Baseline Mini Mental State Examination (MMSE) > 24

4. Malignancy surgery expected to last > 90 min

Exclusion Criteria

Pregnancy, trauma, emergency surgery and obvious infections

Alcohol/drug abuse

On beta blocker therapy

Contraindications for dexmedetomidine administration e.g. sick sinus syndrome ,

secondary heart blocks , hepatic dysfunction , renal dysfunction requiring dialysis or

allergy to dexmedetomidine

Known case of neurological or psychiatric disorders (Parkinsonism, Alzheimer’s

disease)

Patients receiving drugs which predispose to the development of POD like

anticholinergics, opioids and psychoactive drugs, e.g., cocaine, heroin, Lysergic acid

diethylamide (LSD).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath